keyword
https://read.qxmd.com/read/38652392/statewide-survey-of-primary-care-and-subspecialty-providers-on-hepatocellular-carcinoma-risk-stratification-and-surveillance-practices
#1
JOURNAL ARTICLE
Andrew M Moon, Rachel M Swier, Lindsay M Lane, A Sidney Barritt, Hanna K Sanoff, Andrew F Olshan, Stephanie B Wheeler, George N Ioannou, Nicole J Kim, Scott Hagan, Philip Vutien, Thad Benefield, Louise M Henderson
BACKGROUND: Hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis is associated with improved survival. Provision of HCC surveillance is low in the US, particularly in primary care settings. AIMS: To evaluate current hepatitis C virus (HCV) and HCC surveillance practices and physician attitudes regarding HCC risk-stratification among primary care and subspecialty providers. METHODS: Using the Tailored Design Method, we delivered a 34-item online survey to 7654 North Carolina-licensed internal/family medicine or gastroenterology/hepatology physicians and advanced practice providers in 2022...
April 23, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38651448/partial-splenic-embolization-in-a-patient-with-hemophilia-a-and-severe-thrombocytopenia-a-case-report
#2
Tomofumi Nakamura, Mitsuhiro Uchiba, Hirotomo Nakata, Takao Mizumoto, Toru Beppu, Shuzo Matsushita
We report a patient with hemophilia A who underwent partial splenic embolization (PSE) for severe thrombocytopenia secondary to portal hypertension-induced splenomegaly, resulting in a stable long-term quality of life. The patient was diagnosed with hemophilia A and unfortunately contracted human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) from blood products. He subsequently developed progressive splenomegaly due to portal hypertension from chronic HCV, resulting in severe thrombocytopenia...
March 26, 2024: Hematology Reports
https://read.qxmd.com/read/38649402/hbcvtr-an-end-to-end-transformer-with-a-deep-neural-network-hybrid-model-for-anti-hbv-and-hcv-activity-predictor-from-smiles
#3
JOURNAL ARTICLE
Ittipat Meewan, Jiraporn Panmanee, Nopphon Petchyam, Pichaya Lertvilai
Hepatitis B and C viruses (HBV and HCV) are significant causes of chronic liver diseases, with approximately 350 million infections globally. To accelerate the finding of effective treatment options, we introduce HBCVTr, a novel ligand-based drug design (LBDD) method for predicting the inhibitory activity of small molecules against HBV and HCV. HBCVTr employs a hybrid model consisting of double encoders of transformers and a deep neural network to learn the relationship between small molecules' simplified molecular-input line-entry system (SMILES) and their antiviral activity against HBV or HCV...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38649219/liver-disease-associated-glomerulopathies
#4
REVIEW
Swetha R Kanduri, Yonatan Peleg, Shikha Wadhwani
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infect a significant number of individuals globally and their extra-hepatic manifestations, including glomerular disease, are well established. Additionally, liver disease-associated IgA nephropathy is the leading cause of secondary IgA nephropathy with disease course varying from asymptomatic urinary abnormalities to progressive kidney injury. Herein we provide an updated review on the epidemiology, pathogenesis, clinical manifestations, and treatment of HBV- and HCV-related glomerulonephritis as well as IgA nephropathy in patients with liver disease...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38648831/preventive-care-for-men-who-have-sex-with-men
#5
JOURNAL ARTICLE
Stephen McMullan, Therese Anderson, Nadine Elhage
Men who have sex with men (MSM) is an inclusive term used to refer to phenotypic males who have insertive or receptive sex (penile-anal or penile-oral) with other phenotypic males, including people who are transgender or have other gender identities. MSM may report their sexual orientation as homosexual, bisexual, heterosexual, or something else, but this stated sexual orientation may not align with their sexual attraction or behaviors. Several health conditions disproportionately affect MSM compared with age-matched heterosexual men, including HIV infection, anal cancer, syphilis, and depression...
April 2024: American Family Physician
https://read.qxmd.com/read/38645861/-new-progress-in-longitudinal-research-on-the-risk-factors-for-cholelithiasis
#6
JOURNAL ARTICLE
Xin Wang, Ye Bai, Wenqian Yu, Linjun Xie, Shiyi Li, Guoheng Jiang, Hongyu Li, Ben Zhang
Cholelithiasis is a common disease of the digestive system. The risk factors for cholelithiasis have been reported and summarized many times in the published literature, which primarily focused on cross-sectional studies. Due to the inherent limitations of the study design, the reported findings still need to be validated in additional longitudinal studies. Moreover, a number of new risk factors for cholelithiasis have been identified in recent years, such as bariatric surgery, hepatitis B virus infection, hepatitis C virus infection, kidney stones, colectomy, osteoporosis, etc...
March 20, 2024: Sichuan da Xue Xue Bao. Yi Xue Ban, Journal of Sichuan University. Medical Science Edition
https://read.qxmd.com/read/38644678/sofosbuvir-velpatasvir-in-children-3-17-years-old-with-hepatitis-c-virus-infection
#7
JOURNAL ARTICLE
Maureen M Jonas, Rene Romero, Philip Rosenthal, Chuan-Hao Lin, Gabriella Verucchi, Jessica Wen, William F Balistreri, Suzanne Whitworth, Sanjay Bansal, Daniel H Leung, Michael R Narkewicz, Regino P Gonzalez-Peralta, Alessandra Mangia, Wikrom Karnsakul, Girish S Rao, Jiang Shao, Jan de Jong, Bandita Parhy, Anu Osinusi, Kathryn Kersey, Karen F Murray, Etienne M Sokal, Kathleen B Schwarz
BACKGROUND: The safety and efficacy of sofosbuvir-velpatasvir in children aged 3-17 years with chronic hepatitis C virus (HCV) infection of any genotype were evaluated. METHODS: In this Phase 2, multicenter, open-label study, patients received once daily for 12 weeks either sofosbuvir-velpatasvir 400/100 mg tablet (12-17 years), 200/50 mg low dose tablet or oral granules (3-11 years and ≥17 kg), or 150/37.5 mg oral granules (3-5 years and <17 kg)...
April 21, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38643819/elevated-serum-he4-levels-as-a-novel-biomarker-of-disease-severity-and-hepatic-fibrosis-in-autoimmune-hepatitis
#8
JOURNAL ARTICLE
Zhi Yu, Caina Nian, Wenmei Sun, Xinhua Liu, Xueyuan Nian
BACKGROUND: Human epididymis protein 4 (HE4) has been identified as a biomarker for renal fibrosis. This study aimed to evaluate the role of HE4 in the diagnosis and determination of disease severity and hepatic fibrosis in autoimmune hepatitis (AIH). METHODS: Serum HE4 levels were determined via electrochemiluminescence immunoassays in 60 healthy controls and 109 AIH patients (43 without liver cirrhosis and 66 with liver cirrhosis). Liver biopsy was performed on 56 of 109 enrolled patients...
April 19, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38643245/increased-prevalence-but-decreased-survival-of-nonviral-hepatocellular-carcinoma-compared-to-viral-hepatocellular-carcinoma-in-recent-ten-years
#9
JOURNAL ARTICLE
Ting-Chun Chen, Shun-Wen Hsiao, Yang-Yuan Chen, Hsu-Heng Yen, Wei-Wen Su, Yu-Chun Hsu, Siou-Ping Huang, Pei-Yuan Su
Due to the comprehensive hepatitis B virus vaccination program in Taiwan since 1986, the development of antiviral therapy for chronic hepatitis B and chronic hepatitis C infection and covered by National health insurance. Besides, the increased prevalence of nonalcoholic fatty liver disease (NAFLD) and currently, approved therapy for NAFLD remain developing. The etiology of liver-related diseases such as cirrhosis and hepatocellular carcinoma required reinterpretation. This study aimed to analyze the incidence and outcome of hepatocellular carcinoma (HCC) due to viral (hepatitis B and hepatitis C) infection compared to that of nonviral etiology...
April 20, 2024: Scientific Reports
https://read.qxmd.com/read/38642828/virus-induced-diabetes-mellitus-revisiting-infection-etiology-in-light-of-sars-cov-2
#10
REVIEW
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E Butler
Diabetes mellitus (DM) is comprised of two predominant subtypes: type 1 diabetes mellitus (T1DM), accounting for approximately 5 % of cases worldwide and resulting from autoimmune destruction of insulin-producing β-cells, and type 2 (T2DM), accounting for approximately 95 % of cases globally and characterized by the inability of pancreatic β-cells to meet the demand for insulin due to a relative β-cell deficit in the setting of peripheral insulin resistance. Both types of DM involve derangement of glucose metabolism and are metabolic diseases generally considered to be initiated by a combination of genetic and environmental factors...
April 18, 2024: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/38641954/the-role-and-impact-of-viruses-on-cancer-development
#11
REVIEW
Adolfo Contreras, Sandra Amaya Sánchez, Carolina Rodríguez-Medina, Javier Enrique Botero
This review focuses on three major aspects of oncoviruses' role in cancer development. To begin, we discuss their geographic distribution, revealing that seven oncoviruses cause 20% of all human cancers worldwide. Second, we investigate the primary carcinogenic mechanisms, looking at how these oncogenic viruses can induce cellular transformation, angiogenesis, and local and systemic inflammation. Finally, we investigate the possibility of SARS-CoV-2 infection reactivating latent oncoviruses, which could increase the risk of further disease...
April 20, 2024: Periodontology 2000
https://read.qxmd.com/read/38641427/factor-modification-in-the-association-between-high-density-lipoprotein-cholesterol-and-liver-cancer-risk-in-a-nationwide-cohort
#12
JOURNAL ARTICLE
Su Youn Nam, Junwoo Jo, Won Kee Lee, Chang Min Cho
BACKGROUND/AIMS: The effect modification by smoking and menopausal status in the association between high-density lipoprotein cholesterol (HDL-C) and liver cancer risk has not been reported. METHODS: This population-based cohort study included 4.486 million cancer-free individuals among those who underwent national cancer screening in 2010 and were followed up until December 2017. We conducted analyses in populations that excluded people with chronic hepatitis B, chronic hepatitis C and liver cirrhosis (Model I) and that included those diseases (Model III)...
April 11, 2024: International Journal of Epidemiology
https://read.qxmd.com/read/38641023/quantitative-hbeag-is-a-strong-predictor-of-hbeag-loss-among-patients-receiving-pegylated-interferon
#13
JOURNAL ARTICLE
Daniel Q Huang, Liang Shen, Wah Wah Phyo, Gavin Cloherty, Emily K Butler, Mary C Kuhns, Anne L McNamara, Vera Holzmayer, Jeffrey Gersch, Mark Anderson, Wei Lyn Yang, Jing Hieng Ngu, Jason Chang, Jessica Tan, Taufique Ahmed, Yock Young Dan, Yin Mei Lee, Guan Huei Lee, Poh Seng Tan, Mark Muthiah, Htet Toe Wai Khine, Chris Lee, Amy Tay, Seng Gee Lim
BACKGROUND: HBeAg loss is an important endpoint for antiviral therapy in chronic hepatitis B (CHB), however there are no reliable biomarkers to identify patients who will respond to the addition of pegylated interferon to nucleos(t)ide analogue (NA) therapy. AIM: To evaluate the use of serum biomarkers to predict HBeAg loss. METHODS: HBeAg positive CHB participants on NAs who switched-to or added-on 48 weeks pegylated interferon alpha2b (clinicaltrial...
April 17, 2024: Antiviral Research
https://read.qxmd.com/read/38639103/effect-of-hepatic-impairment-on-trilaciclib-pharmacokinetics
#14
JOURNAL ARTICLE
Chao Li, Richard A Preston, Emily Dumas, Andrew Beelen, Thomas C Marbury
Trilaciclib is a first-in-class, intravenous cyclin-dependent kinase 4 and 6 inhibitor approved for reducing the incidence of chemotherapy-induced myelosuppression in adult patients with extensive-stage small cell lung cancer receiving a platinum/etoposide-containing or topotecan-containing regimen. No dose adjustment is recommended for participants with mild hepatic impairment (HI) based on previous population pharmacokinetic (PK) analysis. This open-label, parallel-group study examined the impact of moderate and severe HI on the PK of trilaciclib...
April 19, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38638794/immune-thrombocytopenic-purpura-associated-with-systemic-lupus-erythematosus-helicobacter-pylori-and-hepatitis-b
#15
Bamidele O Johnson, Amisha Nimawat, Nyier W Doar, Thi Nguyen, Malar Thwin
Immune thrombocytopenic purpura (ITP) is a hematologic condition characterized by decreased circulating platelets, resulting in bruising, bleeding gums, and internal bleeding. This disorder can be categorized into two primary forms based on the duration of symptoms and underlying causes. Acute ITP primarily affects young children, typically between the ages of two and six, but it can also impact older children and adults. Viral infections like chickenpox, respiratory infections, or gastroenteritis often precede it...
March 2024: Curēus
https://read.qxmd.com/read/38638100/trends-in-mortality-related-to-hepatitis-b-and-c-from-1990-to-2019-in-the-western-pacific-region
#16
JOURNAL ARTICLE
Hua Zhou, Mengxia Yan, Datian Che, Bin Wu
BACKGROUND/AIMS: : This study aimed to analyze the trends in mortality attributed to hepatitis B and C around the Western Pacific region from 1990 to 2019. METHODS: : We used data from the Global Burden of Disease Study for a systematic analysis. The deaths related to hepatitis B and C were analyzed by age, sex, year, risk factors, geographical location, and Socio-demographic Index (SDI). RESULTS: : From 1990 to 2019, the annual total deaths from hepatitis B decreased from 0...
April 19, 2024: Gut and Liver
https://read.qxmd.com/read/38638067/etiological-changes-of-liver-cirrhosis-and-hepatocellular-carcinoma-complicated-liver-cirrhosis-in-japan-updated-nationwide-survey-from-2018-to-2021
#17
JOURNAL ARTICLE
Hirayuki Enomoto, Norio Akuta, Hayato Hikita, Goki Suda, Jun Inoue, Nobuharu Tamaki, Kiyoaki Ito, Takemi Akahane, Tomokazu Kawaoka, Asahiro Morishita, Eiichi Ogawa, Ryosuke Tateishi, Hitoshi Yoshiji
AIM: A nationwide survey in 2018 showed decreasing involvement of viral hepatitis and increasing involvement of nonviral liver diseases in the etiology of liver cirrhosis (LC) in Japan. An updated nationwide survey was undertaken in 2023. METHODS: Cases of LC diagnosed between 2018 and 2021 were collected from 75 institutions, and the etiologies of LC were investigated. In addition, the data obtained were compared with the results of previous studies. RESULTS: Among the 15 517 cases, alcohol-related liver disease (ALD)-associated LC was the most frequent cause (n = 5,487, 35...
April 18, 2024: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38636654/peripheral-biomarkers-as-a-predictor-of-poor-prognosis-in-severe-cases-of-covid-19
#18
JOURNAL ARTICLE
Gilnei B da Silva, Daiane Manica, Alana P da Silva, Eduarda Valcarenghi, Sabine R Donassolo, Greicy C Kosvoski, Maiqueli E D Mingoti, Jullye Gavioli, Joana V Cassol, Marceli C Hanauer, Mariélly B Hellmann, Filomena Marafon, Amanda G Bertollo, Jesiel de Medeiros, Arthur D Cortez, Gislaine Z Réus, Gabriela G de Oliveira, Zuleide M Ignácio, Margarete D Bagatini
We evaluated glycemia and triglyceride, hepatic, muscular, and renal damage markers, redox profile, and leptin and ghrelin hormone levels of COVID-19 patients. We also realized statistical analysis to verify the potential of biomarkers to predict poor prognosis and the correlation between them in severe cases. We assessed glycemia and the levels of triglycerides, hepatic, muscular, and renal markers in automatized biochemical analyzer. The leptin and ghrelin hormones were assessed by the ELISA assay. Severe cases presented high glycemia and triglyceride levels...
April 16, 2024: American Journal of the Medical Sciences
https://read.qxmd.com/read/38636259/salvia-miltiorrhiza-polysaccharide-mitigates-afb1-induced-liver-injury-in-rabbits
#19
JOURNAL ARTICLE
Lu Zhang, Ying Liu, Qiongyi Zhang, Weiyu Yao, Zenghui Zhao, Xiao Wang, Yongzhan Bao, Wanyu Shi
Aflatoxin B1 (AFB1) is one of the common dietary contaminants worldwide, which can harm the liver of humans and animals. Salvia miltiorrhiza polysaccharide (SMP) is a natural plant-derived polysaccharide with numerous pharmacological activities, including hepatoprotective properties. The purpose of this study is to explore the intervention effect of SMP on AFB1-induced liver injury and its underlying mechanisms in rabbits. The rabbits were administered AFB1 (25 μg/kg/feed) and or treatment with SMP (300, 600, 900 mg/kg/feed) for 42 days...
April 17, 2024: Ecotoxicology and Environmental Safety
https://read.qxmd.com/read/38633442/how-reliable-is-chatgpt-as-a-novel-consultant-in-infectious-diseases-and-clinical-microbiology
#20
JOURNAL ARTICLE
Gülşah Tunçer, Kadir Görkem Güçlü
OBJECTIVE: The study aimed to investigate the reliability of ChatGPT's answers to medical questions, including those sourced from patients and guide recommendations. The focus was on evaluating ChatGPT's accuracy in responding to various types of infectious disease questions. MATERIALS AND METHODS: The study was conducted using 200 questions sourced from social media, experts, and guidelines related to various infectious diseases like urinary tract infection, pneumonia, HIV, various types of hepatitis, COVID-19, skin infections, and tuberculosis...
March 2024: Infect Dis Clin Microbiol
keyword
keyword
53820
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.